JP2014502624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502624A5 JP2014502624A5 JP2013548820A JP2013548820A JP2014502624A5 JP 2014502624 A5 JP2014502624 A5 JP 2014502624A5 JP 2013548820 A JP2013548820 A JP 2013548820A JP 2013548820 A JP2013548820 A JP 2013548820A JP 2014502624 A5 JP2014502624 A5 JP 2014502624A5
- Authority
- JP
- Japan
- Prior art keywords
- liquid medium
- drug
- suspension
- pharmaceutically acceptable
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 claims 21
- 229940079593 drug Drugs 0.000 claims 16
- 239000003814 drug Substances 0.000 claims 16
- 239000000725 suspension Substances 0.000 claims 14
- 238000000034 method Methods 0.000 claims 6
- 239000002245 particle Substances 0.000 claims 5
- 239000012296 anti-solvent Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 238000011026 diafiltration Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims 1
- 238000009295 crossflow filtration Methods 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims 1
- 229940093471 ethyl oleate Drugs 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229940057995 liquid paraffin Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161431942P | 2011-01-12 | 2011-01-12 | |
| US61/431,942 | 2011-01-12 | ||
| PCT/EP2012/050336 WO2012095439A1 (en) | 2011-01-12 | 2012-01-11 | Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502624A JP2014502624A (ja) | 2014-02-03 |
| JP2014502624A5 true JP2014502624A5 (enExample) | 2015-02-26 |
| JP5934719B2 JP5934719B2 (ja) | 2016-06-15 |
Family
ID=45478323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548820A Active JP5934719B2 (ja) | 2011-01-12 | 2012-01-11 | 薬物懸濁液の調製におけるクロスフロー濾過を用いた液体培地交換の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9066864B2 (enExample) |
| EP (1) | EP2663287A1 (enExample) |
| JP (1) | JP5934719B2 (enExample) |
| CN (1) | CN103347499B (enExample) |
| AU (1) | AU2012206621B2 (enExample) |
| BR (1) | BR112013016851B1 (enExample) |
| CA (1) | CA2823972C (enExample) |
| MX (1) | MX346749B (enExample) |
| SG (2) | SG10201807631SA (enExample) |
| WO (1) | WO2012095439A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6478959B2 (ja) * | 2016-09-07 | 2019-03-06 | 株式会社富士薬品 | 粒子含有組成物を製造するためのシステム及び方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340580B1 (en) | 1999-05-12 | 2002-01-22 | Metabolix, Inc. | Methods for purifying polyhydroxy alkanoates |
| WO2001021290A1 (en) * | 1999-09-17 | 2001-03-29 | Danish Separation Systems As | A method and an apparatus for continuous cross-flow diafiltration |
| US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
| WO2003055469A1 (en) * | 2001-12-21 | 2003-07-10 | Celator Technologies Inc. | Improved polymer-lipid delivery vehicles |
| WO2003063877A1 (en) | 2002-02-01 | 2003-08-07 | Akzo Nobel N.V. | Cefquinome composition for intra-mammary administration in cattle |
| ES2265590T3 (es) * | 2002-10-25 | 2007-02-16 | Intervet International Bv | Composicion farmaceutica de liberacion prolongada. |
| ITMI20022674A1 (it) | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
| WO2011072218A2 (en) * | 2009-12-11 | 2011-06-16 | Bind Biosciences | Stable formulations for lyophilizing therapeutic particles |
-
2012
- 2012-01-11 AU AU2012206621A patent/AU2012206621B2/en active Active
- 2012-01-11 CN CN201280005390.0A patent/CN103347499B/zh active Active
- 2012-01-11 SG SG10201807631SA patent/SG10201807631SA/en unknown
- 2012-01-11 WO PCT/EP2012/050336 patent/WO2012095439A1/en not_active Ceased
- 2012-01-11 BR BR112013016851-0A patent/BR112013016851B1/pt active IP Right Grant
- 2012-01-11 US US13/979,231 patent/US9066864B2/en active Active
- 2012-01-11 EP EP12700273.1A patent/EP2663287A1/en not_active Withdrawn
- 2012-01-11 JP JP2013548820A patent/JP5934719B2/ja active Active
- 2012-01-11 MX MX2013008118A patent/MX346749B/es active IP Right Grant
- 2012-01-11 CA CA2823972A patent/CA2823972C/en active Active
- 2012-01-11 SG SG2013053764A patent/SG191963A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD4490B1 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| EA201590059A1 (ru) | Вирусная фильтрация сред клеточных культур | |
| JP2014005302A5 (enExample) | ||
| CN103415520B8 (zh) | 吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用 | |
| AR091538A1 (es) | Purificacion de particulas tipo virus | |
| MX2016000906A (es) | Nuevos derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| MX363327B (es) | Materiales zeoliticos de tipo cha y metodos para su preparacion usando compuestos de cicloalquilamonio. | |
| JP2012518034A5 (enExample) | ||
| WO2014008400A3 (en) | Fill-finish process for peptide solutions | |
| JP2010539337A5 (enExample) | ||
| Bhattacharjee et al. | Role of synergistic π–π stacking and X–H⋯ Cl (X= C, N, O) H-bonding interactions in gelation and gel phase crystallization | |
| JP2012021007A5 (enExample) | ||
| JP2014507474A5 (enExample) | ||
| MX365295B (es) | Reduccion del tamaño de particula de un compuesto antimuscarinico. | |
| JP2017507778A5 (ja) | 高効率な逆浸透膜フィルタ | |
| MY166378A (en) | Zeoltic materials and methods for their preparation using alkenyltrialkylammonium compounds | |
| BR112013029147A2 (pt) | meio de filtração de líquidos, sistema de filtração para filtrar as partículas dos líquidos e processo para a produção de um meio de filtração de líquidos | |
| JP2014502624A5 (enExample) | ||
| JP2014520848A5 (enExample) | ||
| JP2014500802A5 (enExample) | ||
| WO2013024494A3 (en) | Amorphous mixture of lopinavir and ritonavir co-precipitated on copovidone | |
| JP2014505663A5 (enExample) | ||
| SG10201807631SA (en) | Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions | |
| WO2009011584A3 (en) | A method of preparing a pharmaceutical co-crystal composition | |
| RU2012133403A (ru) | Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в конжаковой камеди в бутиловом спирте |